Reginster J Y, Franchimont P
Clin Exp Rheumatol. 1985 Apr-Jun;3(2):155-7.
Side effects are the most frequent reason for discontinuing treatment with Calcitonin. Having been assessed in a previous report that the intranasal administration of Synthetic Salmon Calcitonin (SSCT) is as effective as its intramuscular administration, the aim of this work was to investigate the side-effects of intranasal administration of SSCT in patients who are known to show intolerance after intramuscular administration of the drug. The results show that intranasal administration of SSCT does not give rise to side-effects even in patients known to be intolerant to SSCT by the intramuscular route.
副作用是停止使用降钙素治疗最常见的原因。先前的一份报告评估了合成鲑鱼降钙素（SSCT）鼻内给药与肌肉注射给药效果相同，本研究的目的是调查已知对该药物肌肉注射不耐受的患者鼻内给予SSCT的副作用。结果表明，即使是已知对肌肉注射途径的SSCT不耐受的患者，鼻内给予SSCT也不会产生副作用。
